In the current findings, treatment with 0.1 nmol HFI419 beginning at 2 h post-stroke increased recruitment of astrocytes and CD11b positive cells to the stroke-induced site of injury, both of which are critical for post-stroke neuronal repair and remodelling. This evidence concerns the gene ITGAM and stroke disorder.